Clinical trial · Observational
Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer
An Observation of the Change in Percent Lean Body Mass of Stage III Non-Small Cell Lung Cancer Undergoing Radiation Treatment
NCT00530205CI-TRIAL-00005212withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Learning about the effects of radiation therapy on the body's muscles, organs, and bones in patients with stage III non-small cell lung cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is studying the effects of radiation therapy on the body in patients with stage III non-small cell lung cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Malnutrition | — | UNRESOLVED | — |
| Weight Changes | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| management of therapy complications | Procedure | — | UNRESOLVED |
| physiologic testing | Other | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
| radiation therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (8)
- measure
- Energy and protein consumption measured on an average radiotherapy treatment day by multiple pass method 24-hour analysis for food recall at baseline and treatment end
- measure
- Comparison of energy and protein by mouth intake from baseline to treatment end
- measure
- Comparison of diet quality as measured by Healthy Eating Index (HEI) score from baseline to treatment end
- measure
- Lean body mass versus fat mass using a bioelectrical impedance analysis machine
- measure
- Comparison of body fat to lean body mass percentage at baseline and at treatment end
- measure
- Correlation of energy and protein consumption with lean body mass at baseline and treatment end
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 75 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosed with stage III non-small cell lung cancer (NSCLC) * Plan to begin radiotherapy for NSCLC * Radiotherapy is the only planned therapy for this cancer * No brain metastases PATIENT CHARACTERISTICS: Inclusion criteria: * Must be able to stand without assistance Exclusion criteria: * Unable to comply with study requirements * Native language other than American English * Pacemaker or implanted defibrillator PRIOR CONCURRENT THERAPY: Exclusion criteria: * Receiving chemotherapy in combination with radiotherapy * Concurrent megace or steroids
References
Publications (0)
Data not yet available
No reference posted for this study.